Secular trends in baseline characteristics, treatment retention and response rates in 17,453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration

Sara Nysom  Christiansen; Lykke Midtbøll Ørnbjerg; Simon Horskjær Rasmussen; AG Loft; Merete Lund Hetland; Mikkel Østergaard

Secular trends in baseline characteristics, treatment retention and response rates in 17,453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration

Sara Nysom Christiansen, Lykke Midtbøll Ørnbjerg, Simon Horskjær Rasmussen, AG Loft, Merete Lund Hetland, Mikkel Østergaard

Afdeling for Rygkirurgi, Led- og Bindevævssygdomme

Originalsprog	Engelsk
Artikelnummer	OP0220
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	80
Udgave nummer	Supplement 1
Sider (fra-til)	131-2
Antal sider	2
ISSN	0003-4967
Status	Udgivet - 2021

Citationsformater

Christiansen, S. N., Ørnbjerg, L. M., Rasmussen, S. H., Loft, AG., Hetland, M. L., & Østergaard, M. (2021). Secular trends in baseline characteristics, treatment retention and response rates in 17,453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration. Annals of the Rheumatic Diseases, 80(Supplement 1), 131-2. Artikel OP0220.

Secular trends in baseline characteristics, treatment retention and response rates in 17,453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration. / Christiansen, Sara Nysom ; Ørnbjerg, Lykke Midtbøll; Rasmussen, Simon Horskjær et al.
I: Annals of the Rheumatic Diseases, Bind 80, Nr. Supplement 1, OP0220, 2021, s. 131-2.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Christiansen, SN , Ørnbjerg, LM, Rasmussen, SH, Loft, AG, Hetland, ML & Østergaard, M 2021, 'Secular trends in baseline characteristics, treatment retention and response rates in 17,453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration', Annals of the Rheumatic Diseases, bind 80, nr. Supplement 1, OP0220, s. 131-2.

Christiansen, Sara Nysom ; Ørnbjerg, Lykke Midtbøll ; Rasmussen, Simon Horskjær et al. / Secular trends in baseline characteristics, treatment retention and response rates in 17,453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration. I: Annals of the Rheumatic Diseases. 2021 ; Bind 80, Nr. Supplement 1. s. 131-2.

@article{f5c93152c5d2469b94024e5d7334f792,

title = "Secular trends in baseline characteristics, treatment retention and response rates in 17,453 biona{\"i}ve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration",

author = "Christiansen, {Sara Nysom} and {\O}rnbjerg, {Lykke Midtb{\o}ll} and Rasmussen, {Simon Horskj{\ae}r} and AG Loft and Hetland, {Merete Lund} and Mikkel {\O}stergaard",

note = "COPECARE",

year = "2021",

language = "English",

volume = "80",

pages = "131--2",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier BV",

number = "Supplement 1",

}

TY - ABST

T1 - Secular trends in baseline characteristics, treatment retention and response rates in 17,453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration

AU - Christiansen, Sara Nysom

AU - Ørnbjerg, Lykke Midtbøll

AU - Rasmussen, Simon Horskjær

AU - Loft, AG

AU - Hetland, Merete Lund

AU - Østergaard, Mikkel

N1 - COPECARE

PY - 2021

Y1 - 2021

M3 - Conference abstract in journal

SN - 0003-4967

VL - 80

SP - 131

EP - 132

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Supplement 1

M1 - OP0220

ER -